Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants
LUND, SWEDEN – Immunovia AB, (“Immunovia”) announces today that Patrik Dahlen, CEO of Immunovia, has purchased 250,000 warrants of the 2020/2024 scheme for approximately 400 KSEK. His total holding now amounts to 45,000 shares and 250,000 warrants in Immunovia. The warrants have a subscription price per share of SEK 455. Other management team members have subscribed for 4,000 warrants of the same scheme. For more information, please contact:Patrik Dahlen, CEO, ImmunoviaEmail: patrik.dahlen@immunovia.comTel: +46 73 376 76 64 About ImmunoviaImmunovia AB is a diagnostic company